医学
结缔组织增生
结直肠癌
脂肪组织
危险系数
内科学
比例危险模型
优势比
胃肠病学
腹内脂肪
置信区间
病理
肿瘤科
癌症
肥胖
内脏脂肪
胰腺癌
胰岛素抵抗
作者
Julio Cezar Sillos André,Talita Viana Martins,Priscila Valverde Fernandes,Nina Carrossini Bastos,Fabiana Resende Rodrigues,Gabriela Villaça Chaves,Lívia Costa de Oliveira,Gabrielle da Silva Vargas Silva,Leonardo Borges Murad,Wilza Arantes Ferreira Peres
标识
DOI:10.1017/s0007114525103784
摘要
Abstract Understanding the interplay between adiposity and histopathological features of colorectal tumors is crucial for advancing strategies in disease management. We conducted a retrospective cohort study over an eight-year period (2007–2015), including patients who underwent surgical resection for colorectal cancer (CRC). Body composition was assessed via computed tomography (CT) at the level of the third lumbar vertebra, with visceral adipose tissue (VAT d ) and subcutaneous adipose tissue (SAT d ) radiodensities stratified into tertiles. Systemic inflammatory status was evaluated using the neutrophil-to-lymphocyte ratio (NLR). Logistic regression was employed to analyze the relationship between variables, using odds ratios (OR) with 95% confidence intervals (CI). The Cox proportional hazards model assessed hazard ratios (HRs) with 95% CIs. A total of 231 patients were included (48.9% men, 51.1% women), with 93.6% in CRC stages II and III. Multivariate analyses demonstrated that CRC stages II and III (OR = 5.15, 95% CI: 1.60–16.62; OR = 5.16, 95% CI: 1.59–16.77) and low VAT d (1st and 2nd tertiles; OR = 2.43, 95% CI: 1.30–4.53) were associated with the presence of desmoplasia. In the multivariate Cox analyses, only stage III disease (HR = 4.77, 95% CI: 1.09–20.89) and moderate to accentuated fibrous stroma (HR = 1.90, 95% CI: 1.03–3.46) were identified as predictors of reduced overall survival. These findings suggest that increased visceral adiposity may contribute to the development of a desmoplastic tumor microenvironment. Moreover, the presence of moderate to accentuated fibrous stroma is significantly associated with poorer long-term survival in patients with CRC.
科研通智能强力驱动
Strongly Powered by AbleSci AI